tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZVRA Stock Latest News

Zevra shares not reflecting Miplyffa opportunity, says H.C. Wainwright
The FlyZevra shares not reflecting Miplyffa opportunity, says H.C. Wainwright
15d ago
ZVRA
Zevra Therapeutics executes distribution agreement for MIPLYFFA
PremiumThe Fly
Zevra Therapeutics executes distribution agreement for MIPLYFFA
16d ago
ZVRA
Zevra Therapeutics Announces Interim Financial Leadership Change
PremiumCompany Announcements
Zevra Therapeutics Announces Interim Financial Leadership Change
28d ago
8K
ZVRA
Zevra Therapeutics Appoints Alicia Secor to Board
PremiumCompany Announcements
Zevra Therapeutics Appoints Alicia Secor to Board
1M ago
8K
ZVRA
Zevra Therapeutics appoints Secor to Board of Directors
PremiumThe Fly
Zevra Therapeutics appoints Secor to Board of Directors
1M ago
ZVRA
Zevra Therapeutics CFO Resignation Announced
PremiumCompany AnnouncementsZevra Therapeutics CFO Resignation Announced
2M ago
8K
ZVRA
Zevra Therapeutics CFO R. LaDuane Clifton to step down
Premium
The Fly
Zevra Therapeutics CFO R. LaDuane Clifton to step down
2M ago
ZVRA
Zevra Therapeutics: Strategic Focus on Miplyffa Drives Buy Rating Amid Promising Growth Prospects
Premium
Ratings
Zevra Therapeutics: Strategic Focus on Miplyffa Drives Buy Rating Amid Promising Growth Prospects
2M ago
ZVRA
Zevra Therapeutics Reports Strong Q3 Earnings and Strategic Growth
PremiumCompany Announcements
Zevra Therapeutics Reports Strong Q3 Earnings and Strategic Growth
2M ago
ZVRA
Zevra Therapeutics price target lowered to $24 from $29 at Cantor Fitzgerald
PremiumThe Fly
Zevra Therapeutics price target lowered to $24 from $29 at Cantor Fitzgerald
2M ago
ZVRA
Zevra Therapeutics price target lowered to $24 from $25 at Canaccord
PremiumThe Fly
Zevra Therapeutics price target lowered to $24 from $25 at Canaccord
2M ago
ZVRA
Zevra Therapeutics: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Zevra Therapeutics: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
2M ago
ZVRA
Zevra Therapeutics Reports Strong Q3 2025 Revenue Growth
PremiumCompany AnnouncementsZevra Therapeutics Reports Strong Q3 2025 Revenue Growth
2M ago
ZVRA
Zevra Therapeutics reports Q3 EPS (1c), consensus (2c)
Premium
The Fly
Zevra Therapeutics reports Q3 EPS (1c), consensus (2c)
2M ago
ZVRA
Is ZVRA a Buy, Before Earnings?
Premium
Pre-Earnings
Is ZVRA a Buy, Before Earnings?
2M ago
ZVRA
Zevra Therapeutics: Positive Data and European Expansion Drive Buy Rating
PremiumRatings
Zevra Therapeutics: Positive Data and European Expansion Drive Buy Rating
4M ago
ZVRA
Zevra Therapeutics presents new data on MIPLYFFA
PremiumThe Fly
Zevra Therapeutics presents new data on MIPLYFFA
4M ago
ZVRA
Zevra Therapeutics rumor highlighted in Betaville blog
PremiumThe Fly
Zevra Therapeutics rumor highlighted in Betaville blog
5M ago
ZVRA
Zevra Therapeutics: Strong Buy Rating Amid Impressive Q2 Results and Strategic Growth Potential
PremiumRatings
Zevra Therapeutics: Strong Buy Rating Amid Impressive Q2 Results and Strategic Growth Potential
5M ago
ZVRA
Zevra Therapeutics Faces $58.7 Million Impairment Charge, Raising Concerns Over Financial Stability
PremiumCompany AnnouncementsZevra Therapeutics Faces $58.7 Million Impairment Charge, Raising Concerns Over Financial Stability
5M ago
ZVRA
Zevra Therapeutics’ Earnings Call: Optimism Amid Challenges
Premium
Company Announcements
Zevra Therapeutics’ Earnings Call: Optimism Amid Challenges
5M ago
ZVRA
CoreWeave reports Q2 beat, Gildan to acquire Hanesbrands: Morning Buzz
Premium
The Fly
CoreWeave reports Q2 beat, Gildan to acquire Hanesbrands: Morning Buzz
5M ago
AI
DIS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >